-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RUn1WjMch34UW1E/UXwwYI1mVDyNk2Qfda9M7At97admqNPiyDUdud5fYhipYasP /IPPtZ4OwAyyLbk4FmwXnQ== 0001104659-03-020884.txt : 20030917 0001104659-03-020884.hdr.sgml : 20030917 20030917120806 ACCESSION NUMBER: 0001104659-03-020884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030903 FILED AS OF DATE: 20030917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANAK MARK CENTRAL INDEX KEY: 0001194085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 03898978 BUSINESS ADDRESS: STREET 1: C/O BOSTON BIOMEDIA INC STREET 2: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801900 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON BIOMEDICA INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801900 MAIL ADDRESS: STREET 1: 375 WEST ST CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 4 1 a4.xml 4 X0201 4 2003-09-03 0 0000830656 BOSTON BIOMEDICA INC BBII 0001194085 MANAK MARK 200 STANLEY PLACE LAUREL MD 20707 0 1 0 0 Senior Vice President Common Stock 2003-09-03 4 M 0 518 2.006 A 24507 D Common Stock 4000 I Daughter Option (Right to Buy) 3.25 1997-02-28 2006-02-28 Common Stock 2500 2500 D Option (Right to Buy) 3.25 1999-04-14 2008-04-14 Common Stock 6000 6000 D Option (Right to Buy) 4.00 2001-02-03 2010-02-03 Common Stock 5000 5000 D Option (Right to Buy) 3.08 2003-11-03 2012-02-11 Common Stock 11500 11500 D Option (Right to Buy) 2.70 2003-12-02 2012-12-02 Common Stock 35000 35000 D Table II, Column 6 - Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7 . The options become exercisable in 25 percent annual increments beginning on the date set forth in Table II, Column 6. Mark M. Manak 2003-09-17 -----END PRIVACY-ENHANCED MESSAGE-----